Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP
Choledocholithiasis, Bile Duct Diseases, Bile Duct Carcinoma
About this trial
This is an interventional diagnostic trial for Choledocholithiasis focused on measuring choledocholithiasis, ERCP, cholangiography, biliary stricture, bile ducts, carbon dioxide
Eligibility Criteria
Inclusion Criteria:
- Patients 18 years of age or older
- Patients with choledocholithiasis, benign biliary strictures, malignant biliary strictures
- Biliary pathology suggested or confirmed by imaging with abdominal ultrasonography, CT scan, MRI/MRCP scan, or endoscopic ultrasonography (EUS)
Exclusion Criteria:
- Pregnancy (self reported)
- Presence of cholangitis before ERCP
- Prior history of surgery on the stomach or duodenum that precludes conventional ERCP or prior biliary tree surgery (not including cholecystectomy)
- Failure to selectively cannulate the bile duct
- Life expectancy less than 30 days
- Prisoners
- Patients unable to give consent
Sites / Locations
- University of Virginia Health System
Arms of the Study
Arm 1
Experimental
Single arm
All patients will undergo endoscopic retrograde cholangiopancreatography (ERCP) that is indicated for suspected or confirmed choledocholithiasis or biliary strictures. "Air" contrast cholangiography using carbon dioxide gas will be performed with standard fluoroscopy and digital subtraction fluoroscopic image capture followed by routine cholangiography using iodinated contrast and standard fluoroscopy. Carbon dioxide (CO2) is routinely used in ERCP procedures and would flow into the biliary tree of patients at the time of ERCP, irrespective of this study's interventions. Digital subtraction image capture is a commercially available setting on certain fluoroscopy units that optimizes resolution with air or CO2 used as a contrast medium.